Hetero launches generic Favipiravir in India

July 29, 2020 12:33

Hetero Labs, part of Hetero group on Wednesday announced the launch of generic Favipiravir in India under the brand name 'Favivir.' According to a press release issued by the city-based drug maker, Hetero has been granted the manufacturing and marketing approval for Favipiravir from the Drug Controller General of India (DCGI).

Favivir is the second drug developed by Hetero after Covifor (Remdesivir) used in the treatment of COVID-19. It is an oral antiviral medication that has demonstrated positive clinical outcomes. Favivir improves treatment accessibility to a significant amount of COVID-19 patient population, which usually sustains mild to moderate symptoms.

Hetero's Favivir is priced at Rs 59 per tablet and is marketed and distributed by Hetero Healthcare Ltd. The product is available from July 29 at all retail medical outlets and hospital pharmacies across the country and will be sold only on prescription, it said. -- PTI

« Back to LIVE

TOP STORIES

Hardik's form a blip, says Raina, 'He'll Shine vs Pak'

The T20 World Cup will start on June 1 and will be played in venues in the USA and the Caribbean till June 29.

Iranian Prez's chopper suffers hard landing; search op launched

The details of the incident remain unknown as of now, however, initial reports suggest that the accident involved the president's helicopter and foggy weather.

Bihar school teacher jailed for 'don't vote for Modi' remark in classroom

District education officer Ajay Kumar Singh said teacher Harendra Rajak's conduct was brought to his notice by family members of several students of the government secondary school at Amrakh in Kurhani block.

Abhishek aims to deliver big in every innings

Abhishek said he has benefitted a lot after working with batting great Brian Lara, who was involved with the franchise in the past.

It's scary bowling to Abhishek: Pat Cummins

Abhishek has put fear in the minds of bowlers, including Cummins, his skipper at Sunrisers Hyderabad.